106 related articles for article (PubMed ID: 10967263)
21. Comparison of the blood clearance of triple- and single-helical schizophyllan in mice.
Miura NN; Ohno N; Adachi Y; Aketagawa J; Tamura H; Tanaka S; Yadomae T
Biol Pharm Bull; 1995 Jan; 18(1):185-9. PubMed ID: 7735240
[TBL] [Abstract][Full Text] [Related]
22. β-mannosyl linkages inhibit CAWS arteritis by negatively regulating dectin-2-dependent signaling in spleen and dendritic cells.
Hirata N; Ishibashi K; Sato W; Nagi-Miura N; Adachi Y; Ohta S; Ohno N
Immunopharmacol Immunotoxicol; 2013 Oct; 35(5):594-604. PubMed ID: 23981001
[TBL] [Abstract][Full Text] [Related]
23. Induction of coronary arteritis with administration of CAWS (Candida albicans water-soluble fraction) depending on mouse strains.
Nagi-Miura N; Shingo Y; Adachi Y; Ishida-Okawara A; Oharaseki T; Takahashi K; Naoe S; Suzuki K; Ohno N
Immunopharmacol Immunotoxicol; 2004; 26(4):527-43. PubMed ID: 15658603
[TBL] [Abstract][Full Text] [Related]
24. [Coronary arteritis induced by CAWS (Candida albicans water-soluble fraction) in various strains of mice].
Nagi-Miura N; Adachi Y; Ohno N
Nihon Ishinkin Gakkai Zasshi; 2008; 49(4):287-92. PubMed ID: 19001755
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of plasma (1-->3)-beta-D-glucan measurement by the kinetic turbidimetric Limulus test, for the clinical diagnosis of mycotic infections.
Mori T; Ikemoto H; Matsumura M; Yoshida M; Inada K; Endo S; Ito A; Watanabe S; Yamaguchi H; Mitsuya M; Kodama M; Tani T; Yokota T; Kobayashi T; Kambayashi J; Nakamura T; Masaoka T; Teshima H; Yoshinaga T; Kohno S; Hara K; Miyazaki S
Eur J Clin Chem Clin Biochem; 1997 Jul; 35(7):553-60. PubMed ID: 9263735
[TBL] [Abstract][Full Text] [Related]
26. Effect of Candida albicans cell wall glucan as adjuvant for induction of autoimmune arthritis in mice.
Hida S; Miura NN; Adachi Y; Ohno N
J Autoimmun; 2005 Sep; 25(2):93-101. PubMed ID: 16242302
[TBL] [Abstract][Full Text] [Related]
27. IL-10 is a negative regulatory factor of CAWS-vasculitis in CBA/J mice as assessed by comparison with Bruton's tyrosine kinase-deficient CBA/N mice.
Miura NN; Komai M; Adachi Y; Osada N; Kameoka Y; Suzuki K; Ohno N
J Immunol; 2009 Sep; 183(5):3417-24. PubMed ID: 19675170
[TBL] [Abstract][Full Text] [Related]
28. [Preparation and Biological Characterization of Limulus Factor G-activating Substance of Aspergillus spp.].
Kurone Y; Ishibashi KI; Yamanaka D; Miura NN; Adachi Y; Ohno N
Med Mycol J; 2017; 58(4):E121-E129. PubMed ID: 29187714
[TBL] [Abstract][Full Text] [Related]
29. Solubilization of yeast cell-wall beta-(1-->3)-D-glucan by sodium hypochlorite oxidation and dimethyl sulfoxide extraction.
Ohno N; Uchiyama M; Tsuzuki A; Tokunaka K; Miura NN; Adachi Y; Aizawa MW; Tamura H; Tanaka S; Yadomae T
Carbohydr Res; 1999 Mar; 316(1-4):161-72. PubMed ID: 10420595
[TBL] [Abstract][Full Text] [Related]
30. Coronary Vasculitis Induced in Mice by the Cell Wall Mannoprotein of Candida krusei.
Yanai C; Tanaka H; Miura NN; Ishibashi KI; Yamanaka D; Ohnishi H; Ohno N; Adachi Y
Biol Pharm Bull; 2020 May; 43(5):848-858. PubMed ID: 32161223
[TBL] [Abstract][Full Text] [Related]
31. Soluble (1-->3)-beta-D-glucan purified from Candida albicans: biologic effects and distribution in blood and organs in rabbits.
Yoshida M; Roth RI; Grunfeld C; Feingold KR; Levin J
J Lab Clin Med; 1996 Jul; 128(1):103-14. PubMed ID: 8759942
[TBL] [Abstract][Full Text] [Related]
32. Measurement of (1-->3)-beta-D-glucan in an experimental model of systemic candidiasis.
Kawagoe T; Nakao A; Kanbe T; Tamura H; Tanaka S; Takagi H
Eur Surg Res; 1998; 30(4):290-6. PubMed ID: 9704756
[TBL] [Abstract][Full Text] [Related]
33. [Usefulness of (1-->3)-beta-D-glucan measurement for diagnosis of deep mycosis].
Furuya T; Toyama K
Jpn J Antibiot; 1993 Jun; 46(6):437-43. PubMed ID: 8360979
[TBL] [Abstract][Full Text] [Related]
34. Association of immunological disorders in lethal side effect of NSAIDs on beta-glucan-administered mice.
Takahashi H; Ohno N; Adachi Y; Yadomae T
FEMS Immunol Med Microbiol; 2001 Jul; 31(1):1-14. PubMed ID: 11476975
[TBL] [Abstract][Full Text] [Related]
35. Quantitative assay of (1-3)-beta-D-glucan in culture media of Candida albicans using the G-test.
Nakao A; Kato H; Kanbe T; Tanaka K; Tamura H; Tanaka S; Takagi H
Eur Surg Res; 1994; 26(3):194-200. PubMed ID: 8005180
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics of fungal (1-3)-beta-D-glucans following intravenous administration in rats.
Rice PJ; Lockhart BE; Barker LA; Adams EL; Ensley HE; Williams DL
Int Immunopharmacol; 2004 Sep; 4(9):1209-15. PubMed ID: 15251116
[TBL] [Abstract][Full Text] [Related]
37. Blood clearance of (1-->3)-beta-D-glucan in MRL lpr/lpr mice.
Miura NN; Ohno N; Aketagawa J; Tamura H; Tanaka S; Yadomae T
FEMS Immunol Med Microbiol; 1996 Jan; 13(1):51-57. PubMed ID: 8821398
[TBL] [Abstract][Full Text] [Related]
38. Structure and biological activities of beta-glucans from yeast and mycelial forms of Candida albicans.
Miura NN; Adachi Y; Yadomae T; Tamura H; Tanaka S; Ohno N
Microbiol Immunol; 2003; 47(3):173-82. PubMed ID: 12725286
[TBL] [Abstract][Full Text] [Related]
39. A Model of Left Ventricular Dysfunction Complicated by CAWS Arteritis in DBA/2 Mice.
Hirata N; Ishibashi K; Usui T; Yoshioka J; Hata S; Adachi Y; Nagi-Miura N; Ohta S; Ohno N
Int J Vasc Med; 2012; 2012():570297. PubMed ID: 22830029
[TBL] [Abstract][Full Text] [Related]
40. Positive (1-->3)-beta-D-glucan in blood components and release of (1-->3)-beta-D-glucan from depth-type membrane filters for blood processing.
Usami M; Ohata A; Horiuchi T; Nagasawa K; Wakabayashi T; Tanaka S
Transfusion; 2002 Sep; 42(9):1189-95. PubMed ID: 12430677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
